問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Division of Nuclear Medicine
下載
2024-06-01 - 2026-05-31
Condition/Disease
Test Drug
Participate Sites1Sites
Recruiting1Sites
2018-11-15 - 2025-06-30
Participate Sites5Sites
Terminated5Sites
2023-10-15 - 2029-09-07
Alzheimer's Disease
GSK4527226/ AL101
Participate Sites3Sites
Not yet recruiting3Sites
2021-12-01 - 2024-12-31
Terminated3Sites
2017-08-01 - 2025-01-15
Terminated1Sites
2020-01-15 - 2024-12-31
[18 F]APN-1607
Participate Sites4Sites
Recruiting4Sites
2024-11-20 - 2034-12-31
Participate Sites6Sites
Recruiting6Sites
2020-01-01 - 2027-07-31
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Keytruda® Xtandi®
Recruiting5Sites
2021-09-01 - 2025-04-30
Participate Sites2Sites
Recruiting2Sites
2020-12-25 - 2025-07-31
全部
